ALVOTECH ALVO
ORDINARY SHARES · Common Stock · CUSIP L01800108
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.13. Options: 1 managers hold calls ($551.0k notional), 0 hold puts (—).
Trends to Q2 2022
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $0 | $0 | — |
| Q4 2021 | $0 | $0 | — |
| Q1 2022 | $0 | $0 | — |
| Q2 2022 | $551.0k | $0 | 0.00 |
Biggest buyers
| Bracebridge Capital, LLC | New | +7.0m |
| OAKTREE CAPITAL MANAGEMENT LP | New | +6.3m |
| Lodbrok Capital LLP | New | +2.1m |
| MONTANOVA CAPITAL, LLC | New | +1.0m |
| Temasek Holdings (Private) Ltd | New | +1.0m |
| Sculptor Capital LP | New | +700.0k |
| Oaktree Fund Advisors, LLC | New | +667.4k |
| MILLENNIUM MANAGEMENT LLC | New | +52.4k |
| JANE STREET GROUP, LLC | New | +41.1k |
| Narwhal Capital Management | New | +24.0k |
Biggest sellers
| None |
Biggest calls
| Paloma Partners Management Co | New | $551.0k67.2k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Aztiq Pharma Partners S.a r.l. 13D · may seek influence filed 2026-03-12 | 33.3% |
Celtic Holdings SCA
13D · may seek influence
filed 2026-06-30
Stated purposeItem 4 is hereby amended and supplemented as follows: On June 26, 2026, Celtic Lux purchased aggregate of 10,133,333 Ordinary Shares, at a price of $3.75 per share, for an aggregate investment of $38,000,000 (such investment, the "PIPE Investment") pursuant to the terms of a subscription agreement (the "Subscription Agreement") dated June 16, 2026, by and between Celtic Lux and the Issuer. In connection with the PIPE Investment, pursuant to the Subscription Agreement, Celtic Lux was granted registration rights pursuant to which Celtic Lux may, at any time and from time to time, make a written demand for registration under the Securities Act of 1933, as amended, of all or any portion of the shares purchased by it in the PIPE Investment on any available form of registration statement (a "D… Full filing |
27.5% |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Bracebridge Capital, LLC 18.72% of their portfolio | 7.0m $57.3m | New |
| OAKTREE CAPITAL MANAGEMENT LP 0.62% of their portfolio | 6.3m $52.0m | New |
| Lodbrok Capital LLP 0.81% of their portfolio | 2.1m $14.5m | New |
| Temasek Holdings (Private) Ltd 0.04% of their portfolio | 1.0m $8.2m | New |
| MONTANOVA CAPITAL, LLC 0.31% of their portfolio | 1.0m $8.2m | New |
| Sculptor Capital LP 0.07% of their portfolio | 700.0k $6.6m | New |
| Oaktree Fund Advisors, LLC 9.61% of their portfolio | 667.4k $5.5m | New |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.02% of their portfolio | 500.0k $4.1m | Not comparable |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 52.4k $431.0k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 41.1k $337.0k | New |
| Narwhal Capital Management 0.03% of their portfolio | 24.0k $197.0k | New |
| UBS Group AG 0.00% of their portfolio | 13.6k $112.0k | New |
| GAMCO INVESTORS, INC. ET AL 0.00% of their portfolio | 13.4k $110.0k | New |
| Penserra Capital Management LLC 0.00% of their portfolio | 2.6k $21.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.5k $20.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 1.8k $15.0k | New |
| BARCLAYS PLC 0.00% of their portfolio | 1.3k $10.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |